Biosensors and nanotechnology for cancer diagnosis (lung and bronchus, breast, prostate, and colon): a systematic review. (24th December 2021)

• Record Type: Journal Article
• Authors: Sharifianjazi, Fariborz; Jafari Rad, Azadeh; Bakhtiari, Ameneh; Niazvand, Firoozeh; Esmaeilkhanian, Amirhossein; Bazli, Leila; Abniki, Milad; Irani, Mohammad; Moghanian, Amirhossein
• Is Part Of: Biomedical materials. Volume 17:Number 1(2022)
• Publication Date: 2021-12-24
• Subjects: biosensors -- nanomaterials -- cancer diagnosis -- biomarkers; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1088/1748-605X/ac41fd
• Languages: English
• ISSNs: 1748-6041

Abstract

Abstract: The second cause of death in the world has been reported to be cancer, and it has been on the rise in recent years. As a result of the difficulties of cancer detection and its treatment, the survival rate of patients is unclear. The early detection of cancer is an important issue for its therapy. Cancer detection based on biomarkers may effectively enhance the early detection and subsequent treatment. Nanomaterial-based nanobiosensors for cancer biomarkers are excellent tools for the molecular detection and diagnosis of disease. This review reports the latest advancement and attainment in applying nanoparticles to the detection of cancer biomarkers. In this paper, the recent advances in the application of common nanomaterials like graphene, carbon nanotubes, Au, Ag, Pt, and Fe3 O4 together with newly emerged nanoparticles such as quantum dots, upconversion nanoparticles, inorganics (ZnO, MoS2 ), and metal–organic frameworks for the diagnosis of biomarkers related to lung, prostate, breast, and colon cancer are highlighted. Finally, the challenges, outlook, and closing remarks are given.